Drug Type Small molecule drug |
Synonyms GW-541, JZP 541, JZP541 |
Target |
Mechanism CB modulators(Cannabinoid receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Irritable Mood | Phase 2 | US | 30 Jun 2023 | |
Autism Spectrum Disorder | Phase 2 | - | 17 Feb 2023 |